Molecular Imaging of the Underlying Mechanism of Vessel Wall Inflammation Using Positron Emission Tomography (PET/CT) (NCT07548099)
🩺 Plain-English Summary (8th-Grade Level)
This research study is being conducted to test how an imaging drug called 64Cu-DOTA-ECL1i can be used to image an abdominal aortic aneurysm. 64Cu-DOTA-ECL1i is a drug used with an imaging test called a PET/CT (Positron Emission Tomography/Computed Tomography). The aim is to collect data using a new imaging drug called 64Cu-DOTA-ECL1i that may be able to create images of inflammation in the aorta, which is thought to be important in how aneurysms grow and develop and to understand how consistent these scans are across time and what might affect the inflammation.
Who can join: Review the eligibility criteria below.
Location: Penn Medicine; Perelman School of Medicine — Philadelphia, Pennsylvania
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Penn Medicine; Perelman School of Medicine — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (215) 573-6569
Email: erin.schubert@pennmedicine.upenn.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Abdominal Aortic Aneurysm
- The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System — Lebanon, New Hampshire
- Post-Approval Study of the TREO Abdominal Stent-Graft System — Phoenix, Arizona
- GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study — Stanford, California
- First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA) — Randwick, New South Wales
- Global Fenestrated Anaconda Clinical STudy — Melbourne, Victoria
- The PREHAAAB Trial: Multimodal Prehabilitation for Patients Awaiting Open Abdominal Aortic Aneurysm Repair — Montreal, Quebec
Explore by condition: All Abdominal Aortic Aneurysm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.